Gainers
- ASLAN Pharma ASLN shares moved upwards by 11.9% to $0.4 during Monday's after-market session. The market value of their outstanding shares is at $9.1 million.
- Biora Therapeutics BIOR shares rose 11.64% to $0.75. The company's market cap stands at $26.9 million.
- Qualigen Therapeutics QLGN shares increased by 10.99% to $0.19. The market value of their outstanding shares is at $1.2 million.
- CVRx CVRX stock moved upwards by 9.48% to $12.0. The company's market cap stands at $259.1 million.
- China Pharma Holdings, Inc. Common Stock CPHI stock increased by 8.68% to $0.27.
- Fresh2 Group FRES shares rose 7.56% to $0.34. The market value of their outstanding shares is at $8.3 million.
Losers
- Anitra AZTR shares decreased by 21.3% to $0.18 during Monday's after-market session. The company's market cap stands at $5.3 million.
- Mustang Bio MBIO shares fell 15.98% to $0.63. The company's market cap stands at $17.7 million.
- ENDRA Life Sciences NDRA shares declined by 14.39% to $0.12. The market value of their outstanding shares is at $2.0 million.
- Nexalin Technology NXL shares fell 9.2% to $0.69. The company's market cap stands at $5.0 million.
- PAVmed PAVM stock fell 8.92% to $0.92. The company's market cap stands at $8.6 million.
- Tiziana Life Sciences TLSA shares fell 8.8% to $0.72. The market value of their outstanding shares is at $73.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
BIORBiora Therapeutics Inc
$0.6000-4.31%
CPHIChina Pharma Holding Inc
$0.17409.16%
CVRXCVRx Inc
$12.113.32%
FRESFresh2 Group Ltd
$1.12-2.60%
MBIOMustang Bio Inc
$0.17968.78%
NDRAENDRA Life Sciences Inc
$5.37-%
NXLNexalin Technology Inc
$2.75-10.1%
PAVMPAVmed Inc
$0.6000-0.84%
QLGNQualigen Therapeutics Inc
$4.01-0.74%
TLSATiziana Life Sciences Ltd
$0.84000.96%
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in